Trial conducted by CanCog Technologies shows Apoaequorin improves attention and learning

Quincy Bioscience has announced that apoaequorin improves attention and learning for aged dogs, based on results from a trial conducted by CanCog Technologies.

In the study, twenty-four older beagle were assigned to three cognitively equivalent groups and received placebo or two different doses of the jellyfish protein apoaequorin. The dogs in the apoaequorin group significantly outperformed the control group in tasks designed to measure cognitive abilities.